Advances of nanotechnology in cancer therapy

Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies.

Cancer is one of the deadliest diseases of our time, affecting millions of people worldwide. Despite the significant progress made in cancer treatment over the past few decades, conventional cancer therapies such as chemotherapy, radiation, and surgery have their limitations, including toxicity, drug resistance, and damage to healthy cells and tissues. Therefore, researchers are constantly exploring new avenues for cancer treatment that are safer, more effective, and less invasive. One such avenue is the use of nanotechnology. Nanotechnology involves the manipulation and control of matter at the nanoscale, which is approximately one billionth of a meter. This technology has the potential to revolutionize cancer treatment by offering more targeted and precise therapy. Nanoparticles, for instance, can be engineered to target cancer cells specifically and deliver drugs or other therapeutic agents directly to them, minimizing damage to healthy cells. In this research, we aim to explore the current state of nanotechnology in modern oncology, its potential applications, and its limitations. We review the recent advancements in nanotechnology-based cancer therapy, including the development of targeted nanoparticles for drug delivery, imaging, and theranostics. One of the main advantages of using nanotechnology for cancer treatment is its ability to bypass the blood-brain barrier, allowing for the delivery of therapeutic agents to the brain. This opens up new avenues for the treatment of brain tumors, which are notoriously difficult to treat due to the barrier. Another potential application of nanotechnology in cancer treatment is the use of nanorobots that can be programmed to seek out and destroy cancer cells. These nanorobots can be designed to carry payloads of therapeutic agents or deliver hyperthermia to destroy cancer cells. Despite the many advantages of nanotechnology in cancer treatment, there are also challenges and limitations that need to be addressed. For instance, the toxicity and biocompatibility of nanoparticles need to be carefully evaluated to minimize potential harm to healthy cells and tissues.In conclusion, the role of nanotechnology in modern oncology has the potential to revolutionize cancer treatment. It offers more targeted and precise therapy, and can potentially overcome the limitations of conventional cancer therapies. However, further research is needed to fully explore the potential of nanotechnology in cancer treatment and to address the challenges and limitations associated with it.
In conclusion, the role of nanotechnology in modern oncology has the potential to revolutionize cancer treatment. It offers more targeted and precise therapy, and can potentially overcome the limitations of conventional cancer therapies. However, further research is needed to fully explore the potential of nanotechnology in cancer treatment and to address the challenges and limitations associated with it.

/pdf/revolutionizing-cancer-treatment-the-role-of-nanotechnology-3fpzecqe.pdf

Revolutionizing cancer treatment: the role of nanotechnology in modern oncology

AbstractCurcumin is a phytochemical derived from the bulb of the plant Curcuma longa and is the major component of turmeric. The herb has been used for thousands of years in traditional Ayurvedic and Asian medicine, initially to heal wounds but also to treat diverse conditions. There is a definite need to develop effective, inexpensive, safe treatments for the millions of patients with chronic diseases, including cancer, autoimmune diseases, and degenerative conditions such as arthritis. From the current scenario and study of curcumin, it is believed that data from ongoing and future research will continuously boost researchers to enhance the use of natural, synthetic, and semi synthetic derivatives of the compound as both a primary and secondary therapeutic in a variety of disease states. It has also been reported that curcumin is capable of inhibiting the development of cancer cells and/or inducing many signaling pathways affecting chronic inflammation, including nuclear factor kappa beta (NF-κB) and cyclooxygenase-2 enzymes (COX-2). Curcumin has also shown antiviral and anti-inflammatory effects and to be helpful for both prevention and treatment of the new coronavirus. However, well-designed clinical trials are needed to demonstrate the potential efficacy of curcumin against SARS-CoV-2 infection and its ensuing complications.KeywordsCurcuminTurmericImmunomodulatorCurcuma longaNatural Ingredients 

Immunomodulation Impact of Curcumin and Its Derivative as a Natural Ingredient

http://magneticliquid.narod.ru/autority/364.pdf

Advances of nanotechnology in cancer therapy

Citations

Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies.

Revolutionizing cancer treatment: the role of nanotechnology in modern oncology

Immunomodulation Impact of Curcumin and Its Derivative as a Natural Ingredient

References

Superparamagnetic nanoparticles stabilized by polymerized PEGylated coatings

Related Papers (5)

Recent Advances on Nanotechnology Applications to Cancer Drug Therapy

Cancer and Nanotechnology

Nanotechnology of Cancer Therapy: An Overview

Recent Advances in Cancer Research and Therapy

Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy